KAI Pharmaceuticals Financial Analyst Salary | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals Financial Analyst Salary

The average KAI Pharmaceuticals Financial Analyst earns an estimated $116,491 annually, which includes an estimated base salary of $99,407 with a $17,084 bonus. KAI Pharmaceuticals' Financial Analyst compensation is $29,091 more than the US average for a Financial Analyst. Financial Analyst salaries at KAI Pharmaceuticals can range from $67,000 - $175,000.

The Finance Department at KAI Pharmaceuticals earns $4,984 more on average than the Customer Support Department.

Last updated 5 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$116,491
Average Compensation
$99,407
avg. base
$17,084
avg. bonus

Financial Analyst Salaries at KAI Pharmaceuticals

Financial Analysts earn $2,093 more than Financial Analysts, and $1,291 less than Business Analysts.

Accounting Manager
$139k*
Business Analyst
$118k*
Financial Analyst
$114k*
Senior Accountant
$109k*
Accountant
$85k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

The Finance Department averages $4,984 more than the Customer Support Department, and $129 less than the Operations Department

Operations
$103,725 Avg. total comp.
+$129
Finance
$103,596 Avg. total comp.
Customer Support
$98,612 Avg. total comp.
-$5k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to KAI Pharmaceuticals reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to KAI Pharmaceuticals reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at KAI Pharmaceuticals Rate Their Compensation

The majority of Financial Analysts at KAI Pharmaceuticals believe they're compensated fairly. 100% of Financial Analysts at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company